Lucy Rowell

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

Reginster Jy, S. Adámi, Péter L. Lakatos et al. · Annals of the Rheumatic Diseases · 2005 · 329 citations · Full text

Bone Disease, Once-monthly Oral Ibandronate, Bone Health +8

A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)

Gerd R Burmester, Andrea Rubbert‐Roth, Alain Cantagrel et al. · Annals of the Rheumatic Diseases · 2013 · 237 citations · Full text

Subcutaneous Tocilizumab Versus Placebo in Combination With Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis

Alan Kivitz, Ewa Olech, Michael Borofsky et al. · Arthritis Care & Research · 2014 · 143 citations · Full text

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)

Gerd R Burmester, Andrea Rubbert‐Roth, Alain Cantagrel et al. · Annals of the Rheumatic Diseases · 2015 · 122 citations · Full text

Design of the Tocilizumab in Giant Cell Arteritis Trial

Sebastian Unizony, Bhaskar Dasgupta, Elena Fisheleva et al. · International Journal of Rheumatology · 2013 · 115 citations · Full text